Whales with a lot of money to spend have taken a noticeably bullish stance on Annovis Bio.
Looking at options history for Annovis Bio (NYSE:ANVS) we detected 12 trades.
If we consider the specifics of each trade, it is accurate to state that 58% of the investors opened trades with bullish expectations and 41% with bearish.
From the overall spotted trades, 8 are puts, for a total amount of $385,983 and 4, calls, for a total amount of $139,780.
Expected Price Movements
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $2.5 to $12.5 for Annovis Bio during the past quarter.
Analyzing Volume & Open Interest
In terms of liquidity and interest, the mean open interest for Annovis Bio options trades today is 2744.8 with a total volume of 26,113.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Annovis Bio’s big money trades within a strike price range of $2.5 to $12.5 over the last 30 days.
Annovis Bio 30-Day Option Volume & Interest Snapshot
Largest Options Trades Observed:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
ANVS | PUT | SWEEP | BEARISH | 07/19/24 | $0.6 | $0.5 | $0.6 | $2.50 | $96.9K | 3.6K | 7.9K |
ANVS | PUT | SWEEP | BEARISH | 07/19/24 | $0.6 | $0.5 | $0.6 | $2.50 | $84.3K | 3.6K | 5.5K |
ANVS | PUT | SWEEP | BULLISH | 07/19/24 | $0.6 | $0.55 | $0.55 | $2.50 | $66.0K | 3.6K | 3.3K |
ANVS | CALL | SWEEP | BULLISH | 06/21/24 | $2.0 | $1.85 | $2.0 | $10.00 | $37.6K | 1.1K | 118 |
ANVS | CALL | TRADE | BULLISH | 10/18/24 | $2.65 | $2.0 | $2.5 | $12.50 | $37.5K | 55 | 150 |
About Annovis Bio
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson’s and Alzheimer’s diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration – including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
In light of the recent options history for Annovis Bio, it’s now appropriate to focus on the company itself. We aim to explore its current performance.
Annovis Bio’s Current Market Status
Currently trading with a volume of 1,012,901, the ANVS’s price is up by 6.46%, now at $8.9.
RSI readings suggest the stock is currently…
Click Here to Read the Full Original Article at Cryptocurrencies Feed…